Valenveras – Analysis
Determine Critical data about potency, Cannabinoids, Terpenes In One Scan Timely decisions about quality and compliance Lower operating costs More frequent analysis
In regulated markets, laboratory cannabis analysis is a key process that transforms cultivation into reliable medicine. Specialized cannabis testing labs employ validated protocols and advanced analysis equipment to verify both safety and efficacy. These methods not only meet regulatory frameworks but also sustain the credibility of the entire medical cannabis industry. At the same time, in-house testing solutions such as NeoSpectra Valenveras offer the possibility of lab-like results in seconds, providing growers and producers with rapid, onsite insights to complement external laboratory validation.
The integrity of medical products depends on rigorous cannabis safety testing:
Aligned with cannabis ISO testing methods, these procedures create reproducible results across international laboratories.
Determining therapeutic strength often begins with cannabis potency and cannabinoid profile testing, one of the most widely requested analyses in regulated markets.
The potency result is the sum of the Total THC and Total CBD. Laboratories use a specific formula to report Total THC and Total CBD to reflect the maximum potential potency once the product is consumed. The formula accounts for the molecular weight lost when the acid drops its carboxyl group (carbon dioxide):
Total THC = D9-THC + (THCA x 0.877)
Total CBD = CBD + (CBDA x 0.877)
Among the available tools, NIR potency testing cannabis has gained relevance for its ability to deliver rapid, non-destructive measurements directly on the plant material or finished product. A NIR cannabis potency analyzer enables fast screening with minimal sample preparation, making it ideal for process monitoring in real time. When more detailed separation is needed, chromatographic methods, such as High-Performance Liquid Chromatography (HPLC) for cannabinoid testing and Gas Chromatography–Mass Spectrometry (GC-MS), which is popular for measuring terpenes, complement the results, ensuring regulatory compliance and scientific accuracy.
By standardizing cannabis potency and profile analysis, consistency and reliability are guaranteed for prescribers and patients.
Advanced molecular biology extends testing beyond chemistry:
Through proactive cannabis qPCR testing, producers minimize crop losses while securing genetic fidelity.
Uniformity in formulations is another critical step. Homogeneity testing cannabis products ensures even cannabinoid distribution across oils, edibles, and capsules. Complementary nutritional analysis testing cannabis adds value, particularly in wellness-oriented formulations where potency and nutrition must align.
The reliability of cannabis analysis depends on harmonized ISO methods. Standardization promotes reproducibility, supports clinical research, and strengthens global trust in cannabis-derived medicines.
From cannabis potency and profile testing to contaminant control, genetic screening, and product homogeneity, the analytical process is what elevates the plant from raw biomass to credible therapy. Without rigorous cannabis analysis, the industry could not ensure safety, efficacy, or international recognition.
Determine Critical data about potency, Cannabinoids, Terpenes In One Scan Timely decisions about quality and compliance Lower operating costs More frequent analysis
This starter bundle will provide all the necessary reagents to get started testing for these viruses. Pure Prep Solution (96 rxn pre-aliquoted)
This bundle will provide all the necessary reagents to test 200 samples. Pure Prep Solution RT-qPCR Master Kit v2 PathoSEEK® Hop Latent